Biogen Inc. buy dasgutemorchen
Start price
20.07.11
/
50%
€75.30
Target price
12.01.12
€80.00
Performance (%)
19.26%
End price
12.01.12
€89.80
Summary
This prediction ended on 12.01.12 with a price of €89.80. The prediction had a final performance of 19.26%. dasgutemorchen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -1.327% | -1.327% | 2.330% | -46.135% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by dasgutemorchen for this prediction
In the thread Biogen Inc. diskutieren
Biotech im Aufwind
Im fachmagazin Nature Medicine ist eine studie zur behandlung v. MS veröffentlicht; damit gute aussicht marktführer zu bleiben - od. übernahmekandidat ? !
(Vom Mitglied beendet)


